Firm

Anna Mae Koo and Owen Tse of Vivien Chan & Co examine how trademarks, personality rights, and AI regulations can help celebrities and influencers combat deepfake impersonation in China

Ke Mou and Stephen Zou of Liu Shen & Associates outline China’s evolving framework on pharmaceutical intellectual property protection, examining how data exclusivity, patent term extension, patent linkage, and enforcement mechanisms support innovation

Selin Sinem Erciyas of Gün + Partners examines whether the EU Pharma Package’s expanded Bolar exemption aligns with the TRIPS Agreement, drawing lessons from Türkiye’s long-standing pharmaceutical patent jurisprudence

A recent case establishes that commercial considerations outweigh genus or species factors when assessing similarity between goods designated in trademark applications and protected crop varieties, says Min Son of HANOL ClassHankyul IP & Law

Igor Charles and Théo Coquis of INLEX analyse a Paris Judicial Court ruling confirming that trademark exhaustion applies to bundled genuine products where the original packaging remains unaltered

Kerstin Wolff of Maiwald explains how patents, plant variety rights, and new genomic techniques intersect in Europe, and what breeders and biotech innovators should consider when protecting plant intellectual property